DataMeds AI Inc. stocks have been trading up by 15.46 percent after unveiling a breakthrough healthcare analytics platform.

He also describes a complementary technique for cases requiring full amino acid analysis: hydrolyzing the peptide completely, ...

New research to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, ...

Rare but serious long-term complications of GLP-1 medications include gallbladder disease and eye problems caused by rapid drops in blood sugar. Weight loss on GLP-1s may also cause loss of muscle and ...

One user, in a testimonial the company sent me, said that Mindful Art Break helped them “contemplate something other than ...

From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, ...

GLP-1 medications slow gastric emptying and often decrease appetite, making it challenging to eat enough protein to preserve lean muscle mass during weight loss. Focus on nutrient-dense, low fat ...

The medical device market is expected to grow to almost $800 billion by 2030. Here's a list of the year's best opportunities. The United States has a $115.5 billion trade deficit in pharmaceutical ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

Now, experts are exploring GLP-1s as a novel therapy for another disease: addiction. Addiction is a serious disease that looks different for everyone. In 2024, nearly 17% of people ages 12 and up ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology.

A mention of ‘GLP-1’ would have drawn a sea of blank faces just a few years ago. But now the term has become widely recognised as the catch-all name for weight-loss drugs. GLP-1, or its full name ...